Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States
- PMID: 15917574
- PMCID: PMC1140551
- DOI: 10.1128/AAC.49.6.2561-2564.2005
Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States
Abstract
A total of 986 isolates of Haemophilus influenzae from patients with respiratory tract infections in 45 United States medical centers were characterized during the winter of 2002-2003. beta-Lactamase production was noted with 26.2% of isolates; 14.6% were resistant to trimethoprim-sulfamethoxazole. Resistance to other relevant antimicrobial agents was extremely uncommon. In comparison to the results of four previous national surveys conducted since 1994, the prevalence of beta-lactamase production with this pathogen appears to be decreasing.
References
-
- Barriere, S. L., and J. A. Hindler. 1993. Ciprofloxacin-resistant Haemophilus influenzae infection in a patient with chronic lung disease. Ann. Pharmacother. 27:309-310. - PubMed
-
- Biedenbach, D. J., and R. N. Jones. 2003. Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to flouroquinolones: prevalence results from the SENTRY antimicrobial surveillance program. Diagn. Microbiol. Infect. Dis. 46:55-61. - PubMed
-
- Doern, G. V. 1996. Antimicrobial resistance among lower respiratory tract isolates of Haemophilus influenzae: results of a 1992-93 western Europe and USA collaborative surveillance study. The Alexander Project Collaborative Group. J. Antimicrob. Chemother. 38:59-69. - PubMed
-
- Doern, G. V., and S. D. Brown. 2004. Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-01. J. Infect. 48:56-65. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
